137 related articles for article (PubMed ID: 34348419)
21. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.
Chen Z; Wang O; Nie M; Elison K; Zhou D; Li M; Jiang Y; Xia W; Meng X; Chen S; Xing X
Mol Cell Endocrinol; 2015 Jan; 399():32-42. PubMed ID: 25301327
[TBL] [Abstract][Full Text] [Related]
22. Aromatase deficiency: A case series of 46, XX Chinese children and a systematic review of the literature.
Fan L; Zhang B; Li L; Gong C
Clin Endocrinol (Oxf); 2020 Dec; 93(6):687-695. PubMed ID: 32623730
[TBL] [Abstract][Full Text] [Related]
23. A novel compound heterozygous variant in CYP19A1 resulting in aromatase deficiency with normal ovarian tissue.
Acar S; Erbaş İM; Paketçi A; Onay H; Çankaya T; Gürsoy S; Özhan B; Abacı A; Özer E; Olguner M; Böber E; Demir K
Turk J Pediatr; 2020; 62(5):826-830. PubMed ID: 33108086
[TBL] [Abstract][Full Text] [Related]
24. Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression.
Fukami M; Tsuchiya T; Vollbach H; Brown KA; Abe S; Ohtsu S; Wabitsch M; Burger H; Simpson ER; Umezawa A; Shihara D; Nakabayashi K; Bulun SE; Shozu M; Ogata T
J Clin Endocrinol Metab; 2013 Dec; 98(12):E2013-21. PubMed ID: 24064691
[TBL] [Abstract][Full Text] [Related]
25. Aromatase excess syndrome in a Chinese boy due to a novel duplication at 15q21.2.
Tan X; Wu X; Chen J; Wu Y; Li S; Chen X; Zhang X
J Pediatr Endocrinol Metab; 2019 Jan; 32(1):85-88. PubMed ID: 30530883
[TBL] [Abstract][Full Text] [Related]
26. 46,XX aromatase deficiency: A single-center experience with the varied spectrum and recurrent variants, and a systematic review of hormonal parameters.
Yami Channaiah C; Memon SS; Sarathi V; Lila AR; Barnabas R; Raghav D; Bhandare VV; Arya S; Thakkar H; Patil VA; Karlekar M; Kunwar A; Bandgar T
Ann Endocrinol (Paris); 2024 Feb; 85(1):48-55. PubMed ID: 37348676
[TBL] [Abstract][Full Text] [Related]
27. Aromatase deficiency in a male patient - Case report and review of the literature.
Miedlich SU; Karamooz N; Hammes SR
Bone; 2016 Dec; 93():181-186. PubMed ID: 27693882
[TBL] [Abstract][Full Text] [Related]
28. Estrogen deficiency reversibly induces telomere shortening in mouse granulosa cells and ovarian aging in vivo.
Bayne S; Li H; Jones ME; Pinto AR; van Sinderen M; Drummond A; Simpson ER; Liu JP
Protein Cell; 2011 Apr; 2(4):333-46. PubMed ID: 21574023
[TBL] [Abstract][Full Text] [Related]
29. [A clinical case of aromatase excess syndrome associated with 15Q21.2 duplication].
Kasyanova YV; Chernyak IY; Voronina IK; Kalinchenko NY
Probl Endokrinol (Mosk); 2020 Aug; 66(2):79-84. PubMed ID: 33351351
[TBL] [Abstract][Full Text] [Related]
30. Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.
Burckhardt MA; Obmann V; Wolf R; Janner M; Flück CE; Mullis PE
Gynecol Endocrinol; 2015 May; 31(5):349-54. PubMed ID: 25585547
[TBL] [Abstract][Full Text] [Related]
31. Congenital disorders of estrogen biosynthesis and action.
Fukami M; Ogata T
Best Pract Res Clin Endocrinol Metab; 2022 Jan; 36(1):101580. PubMed ID: 34538723
[TBL] [Abstract][Full Text] [Related]
32. Hereditary gynaecomastia.
LJUNGBERG T
Acta Med Scand; 1960 Dec; 168():371-9. PubMed ID: 13762869
[No Abstract] [Full Text] [Related]
33. Recognizing rare disorders: aromatase deficiency.
Jones ME; Boon WC; McInnes K; Maffei L; Carani C; Simpson ER
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):414-21. PubMed ID: 17452968
[TBL] [Abstract][Full Text] [Related]
34. Hypothesis: Persistently elevated hCG causes gestational ovarian overstimulation associated with prolonged postpartum hyperandrogenism in mothers of aromatase-deficient babies.
Riedl S; Springer A; Häusler G; Price G; Richter-Unruh A; Stener-Victorin E; Wudy SA
J Clin Endocrinol Metab; 2013 Aug; 98(8):3115-20. PubMed ID: 23824416
[TBL] [Abstract][Full Text] [Related]
35. Aromatase deficiency and estrogen resistance: from molecular genetics to clinic.
Bulun SE
Semin Reprod Med; 2000; 18(1):31-9. PubMed ID: 11305285
[TBL] [Abstract][Full Text] [Related]
36. Genetic studies to characterize the origin of the mutation in placental aromatase deficiency.
Harada N; Ogawa H; Shozu M; Yamada K
Am J Hum Genet; 1992 Sep; 51(3):666-72. PubMed ID: 1496995
[TBL] [Abstract][Full Text] [Related]
37. Molecular Basis of CYP19A1 Deficiency in a 46,XX Patient With R550W Mutation in POR: Expanding the PORD Phenotype.
Parween S; Fernández-Cancio M; Benito-Sanz S; Camats N; Rojas Velazquez MN; López-Siguero JP; Udhane SS; Kagawa N; Flück CE; Audí L; Pandey AV
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32060549
[TBL] [Abstract][Full Text] [Related]
38. 17β-Estradiol is critical for the preovulatory induction of prostaglandin E(2) synthesis in mice.
Toda K; Ono M; Yuhki K; Ushikubi F; Saibara T
Mol Cell Endocrinol; 2012 Oct; 362(1-2):176-82. PubMed ID: 22713853
[TBL] [Abstract][Full Text] [Related]
39. Accelerated Pubertal Tempo in a 46,XY Aromatase-Deficient Patient.
Costanzo M; Garcia-Feyling J; Saraco N; Marino R; Pérez Garrido N; Touzon MS; Viterbo G; Lazzati JM; Patiño HC; Mattone C; Maceiras M; Belgorosky A; Guercio G
Horm Res Paediatr; 2018; 90(4):275-282. PubMed ID: 30173221
[TBL] [Abstract][Full Text] [Related]
40. Long-term Effect of Aromatase Inhibition in Aromatase Excess Syndrome.
Binder G; Nakamura A; Schweizer R; Ogata T; Fukami M; Nagasaki K
J Clin Endocrinol Metab; 2021 Apr; 106(5):1491-1500. PubMed ID: 33513243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
